Identification of Asiaticoside from <i>Centella erecta</i> (Apiaceae) as Potential Apyrase Inhibitor by UF-UHPLC-MS and Its In Vivo Antischistosomal Activity
Schistosomiasis, caused by parasites of the genus <i>Schistosoma</i>, is a neglected disease with high global prevalence, affecting more than 240 million people in several countries. Praziquantel (PZQ) is the only drug currently available for the treatment. <i>S. mansoni</i>...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Schistosomiasis, caused by parasites of the genus <i>Schistosoma</i>, is a neglected disease with high global prevalence, affecting more than 240 million people in several countries. Praziquantel (PZQ) is the only drug currently available for the treatment. <i>S. mansoni</i> NTPDases (known as SmNTPDases, ATP diphosphohydrolases or <i>ecto</i>-apyrases) are potential drug targets for the discovery of new antischistosomal drugs. In this study, we screen NTPDases inhibitors from <i>Centella erecta</i> (Apiaceae) using an ultrafiltration combined UHPLC-QTOF-MS method and potato apyrase, identifying asiaticoside as one of the apyrase-binding compounds. After isolation of asiaticoside from <i>C. erecta</i> extract, we assessed its in vivo antischistosomal activities against <i>Schistosoma mansoni</i> worms and its in vitro enzymatic apyrase inhibition. Also, molecular docking analysis of asiaticoside against potato apyrase, <i>S. mansoni</i> NTPDases 1 and 2 were performed. Asiaticoside showed a significant in vitro apyrase inhibition and molecular docking studies corroborate with its possible actions in potato apyrase and <i>S. mansoni</i> NTPDases. In mice harboring a patent <i>S. mansoni</i> infection, a single oral dose of asiaticoside (400 mg/kg. p.o.) showed significantly in vivo antischistosomal efficacy, markedly decreasing the total worm load and egg burden, giving support for further exploration of apyrase inhibitors as antischistosomal agents. |
---|---|
Item Description: | 10.3390/pharmaceutics14051071 1999-4923 |